MedTrace Logo

PUMA Implementation 2

NCT03713931 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2018-12-27

No results posted yet for this study

Summary

COPD is underdiagnosed and spirometry is not widely available in primary care settings. This study explore the value of PUMA´s questionnaire in a case finding strategy to detect patients to perform spirometry in a real world scenario of primary care health venues.

Conditions

  • Adult
  • Risk Factors
  • Primary Care
  • COPD
  • Screening Score
  • Spirometry
  • Diagnosis

Interventions

DIAGNOSTIC_TEST

PUMA Score questionnaire

Every patient who meet the criteria for active search (older than 40 years, smokers or ex-smokers of more than 10 pack-years who attend the usual care in the first level of care) will be scored with the PUMA´s questionnaire in an application and electronic database (RedCap) specially designed for the active search of cases. Patients with PUMA´s score ≥ 5, and without exclusion criteria for spirometry will be referred to perform spirometry at the institution

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Gustavo Zabert, MD

    lead INDUSTRY

Principal Investigators

  • Gustavo E Zabert, MD · ALAT

  • Ignacio Zabert, MD · ALAT

  • Fabian Mariluan, MD · ALAT

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-14
Primary Completion
2018-12-21
Completion
2019-01-21

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03713931 on ClinicalTrials.gov